Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $10 billion point-of-care testing market.
Blackrock Neurotech
3 followers
Imperative Care
1 follower
Ceribell
1 follower
Cytrellis Biosystems
1 follower
Anteris Technologies
2 followers
Biotex Inc
2 followers
PROCEPT BioRobotics
5 followers
Regulatory Affairs Professionals Society (RAPS)
1 follower
Stryker
232 followers
Boston Scientific
167 followers
Becton Dickinson
145 followers
Baxter
135 followers